US Stock MarketDetailed Quotes

FGEN FibroGen

Watchlist
  • 0.389
  • +0.001+0.36%
Close Nov 27 16:00 ET
  • 0.390
  • +0.001+0.23%
Post 19:43 ET
39.20MMarket Cap-316P/E (TTM)

About FibroGen Company

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

Company Profile

SymbolFGEN
Company NameFibroGen
Listing DateNov 14, 2014
Issue Price18.00
Founded1993
CEOMr. Thane Wettig
MarketNASDAQ
Employees486
Fiscal Year Ends12-31
Address350 Bay Street,Suite 100-6009
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94133
Phone1-415-978-1200
Websitehttp://www.fibrogen.com

Company Executives

  • Name
  • Position
  • Salary
  • Thane Wettig
  • Chief Executive Officer and Director
  • 3.64M
  • Juan Graham
  • Chief Financial Officer and Principal Accounting Officer
  • 3.09M
  • Christine Chung
  • Senior Vice President, China Operations
  • 3.11M
  • James A. Schoeneck
  • Chairman of the Board
  • 499.58K
  • Jeffrey W. Henderson
  • Independent Director
  • 370.53K
  • Jeffrey L. Edwards
  • Independent Director
  • 385.53K
  • Dr. Maykin Ho, PhD
  • Independent Director
  • 375.53K
  • Dr. Aoife M. Brennan, M.B.
  • Independent Director
  • 373.03K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data